Hernandez-Gea, V., & Friedman, S. L. (2011). Pathogenesis of liver fibrosis. Annual review of pathology: mechanisms of disease, 6, 425–456.

Article  CAS  Google Scholar 

Schuppan, D., & Kim, Y. O. (2013). Evolving therapies for liver fibrosis. The Journal of clinical investigation, 123(5), 1887–1901.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cordero-Espinoza, L., & Huch, M. (2018). The balancing act of the liver: tissue regeneration versus fibrosis. The Journal of clinical investigation, 128(1), 85–96.

Article  PubMed  PubMed Central  Google Scholar 

Mao, Y., Zhang, S., Yu, F., Li, H., Guo, C., & Fan, X. (2015). Ghrelin attenuates liver fibrosis through regulation of TGF-β1 expression and autophagy. International journal of molecular sciences, 16(9), 21911–21930.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mannaerts, I., Schroyen, B., Verhulst, S., Van Lommel, L., Schuit, F., Nyssen, M., & van Grunsven, L. A. (2013). Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration. PloS one, 8(12), e84071.

Article  PubMed  PubMed Central  Google Scholar 

Fabregat, I., Moreno-Càceres, J., Sánchez, A., Dooley, S., Dewidar, B., Giannelli, G., & Consortium, I. L. (2016). TGF‐β signalling and liver disease. The FEBS journal, 283(12), 2219–2232.

Article  CAS  PubMed  Google Scholar 

Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014). Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology, 147(4), 765–783. e764.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, H. H., Chen, D. Q., Wang, Y. N., Feng, Y. L., Cao, G., Vaziri, N. D., & Zhao, Y. Y. (2018). New insights into TGF-β/Smad signaling in tissue fibrosis. Chemico-biological interactions, 292, 76–83.

Article  CAS  PubMed  Google Scholar 

Fang, Q. Q., Wang, X. F., Zhao, W. Y., Ding, S. L., Shi, B. H., Xia, Y., & Tan, W. Q. (2018). Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways. Scientific Reports, 8(1), 3332.

Article  PubMed  PubMed Central  Google Scholar 

Liu, J., Kong, D., Qiu, J., Xie, Y., Lu, Z., Zhou, C., & Wang, Y. (2019). Praziquantel ameliorates CCl4-induced liver fibrosis in mice by inhibiting TGF‐β/Smad signalling via up‐regulating Smad7 in hepatic stellate cells. British journal of pharmacology, 176(24), 4666–4680.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ying, H. Z., Chen, Q., Zhang, W. Y., Zhang, H. H., Ma, Y., Zhang, S. Z., & Yu, C. H. (2017). PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics. Molecular medicine reports, 16(6), 7879–7889.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Czochra, P., Klopcic, B., Meyer, E., Herkel, J., Garcia-Lazaro, J. F., Thieringer, F., & Lohse, A. W. (2006). Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. Journal of hepatology, 45(3), 419–428.

Article  CAS  PubMed  Google Scholar 

Niba, E. T. E., Nagaya, H., Kanno, T., Tsuchiya, A., Gotoh, A., Tabata, C., & Nishizaki, T. (2013). Crosstalk between PI3 kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK pathways downstream PDGF receptor. Cellular Physiology and Biochemistry, 31(6), 905–913.

Article  CAS  PubMed  Google Scholar 

Liu, X., Huang, K., Zhang, R. J., Mei, D., & Zhang, B. (2020). Isochlorogenic acid A attenuates the progression of liver fibrosis through regulating HMGB1/TLR4/NF-κB signaling pathway. Frontiers in pharmacology, 11, 582.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fayed, H. M., Asaad, G. F., Elbaset, M. A., Sharaf, O. A., Mahmoud, S. S., Amin, M. M., El-Gendy, Z. A., Ibrahim, F. A., Abdelgayed, S. S., & Abdel-Rahman, R. F. (2025). Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways (Vol. 398, pp. 16131–16148). Naunyn-Schmiedeberg’s Archives of Pharmacology.

Google Scholar 

ALSuhaymi, N., Alsugoor, M. H., Shokry, A. A., Fayed, H. M., Mohamed, B. M., Afifi, S. M., Esatbeyoglu, T., Korany, R. M., & Elbaset, M. A. (2025). Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways. Frontiers in Pharmacology, 16, 1586231.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almalki, R. S., Gazzaz, M., Miski, S. F., Fayed, H. M., Mohamed, B. M., Hessin, A. F., Afifi, S. M., Esatbeyoglu, T., Korany, R. M., & Elbaset, M. A. (2025). Repositioning gemigliptin for the alleviation of thioacetamide-induced liver fibrosis in rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR axis and apoptosis. European Journal of Pharmaceutical Sciences, 212, 107192.

Article  CAS  PubMed  Google Scholar 

Hassan, N. H., Kamel, G. M., Fayed, H. M., Korany, R. M. S., & Ramadan, A. (2025). Dapagliflozin alleviates thioacetamide induced-liver fibrosis in rats via controlling the Nrf2/HO-1 and TLR4/TGF-β1/PI3K signaling pathways. Immunopharmacology and Immunotoxicology, 47(3), 392–405.

Article  CAS  PubMed  Google Scholar 

Abd El-Rahman, S. S., & Fayed, H. M. (2019). Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat. Journal of Tissue Engineering and Regenerative Medicine, 13(12), 2131–2141.

Article  CAS  PubMed  Google Scholar 

Scott, C. L., Zheng, F., De Baetselier, P., Martens, L., Saeys, Y., De Prijck, S., & Raes, G. (2016). Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nature communications, 7(1), 10321.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., & Gordon-Walker, T. T. (2012). Differential Ly-6 C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proceedings of the National Academy of Sciences, 109(46), E3186–E3195.

Article  CAS  Google Scholar 

Brempelis, K. J., & Crispe, I. N. (2016). Infiltrating monocytes in liver injury and repair. Clinical & translational immunology, 5(11), e113.

Article  Google Scholar 

Seki, E., De Minicis, S., Inokuchi, S., Taura, K., Miyai, K., Van Rooijen, N., & Brenner, D. A. (2009). CCR2 promotes hepatic fibrosis in mice. Hepatology, 50(1), 185–197.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liaskou, E., Zimmermann, H. W., Li, K. K., Oo, Y. H., Suresh, S., Stamataki, Z., & Syn, W. K. (2013). Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology, 57(1), 385–398.

Article  CAS  PubMed  Google Scholar 

Povero, D., Busletta, C., Novo, E., di Bonzo, L. V., Cannito, S., Paternostro, C., & Parola, M. (2010). Liver fibrosis: a dynamic and potentially reversible process. Histology and histopathology, 25, 1075–1091.

PubMed  Google Scholar 

Ferreira, J. F., Luthria, D. L., Sasaki, T., & Heyerick, A. (2010). Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. Molecules, 15(5), 3135–3170.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramana, K. V., Singhal, S. S., & Reddy, A. B. (2014). Therapeutic potential of natural pharmacological agents in the treatment of human diseases. BioMed research international, 2014.

Bora, K. S., & Sharma, A. (2011). The genus Artemisia: a comprehensive review. Pharmaceutical Biology, 49(1), 101–109.

Article  PubMed  Google Scholar 

Bhat, R. R., Rehman, M. U., Shabir, A., Rahman Mir, M. U., Ahmad, A., Khan, R., & Ganaie, M. A. (2019). Chemical composition and biological uses of Artemisia absinthium (wormwood). Plant and Human Health, Volume 3: Pharmacology and Therapeutic Uses, 37–63.

Ali, M., & Abbasi, B. H. (2013). Production of commercially important secondary metabolites and antioxidant activity in cell suspension cultures of Artemisia absinthium L. Industrial Crops and Products, 49, 400–406.

Article  CAS  Google Scholar 

Kordali, S., Cakir, A., Mavi, A., Kilic, H., & Yildirim, A. (2005). Screening of chemical composition and antifungal and antioxidant activities of the essential oils from three Turkish Artemisia species. Journal of agricultural and food chemistry, 53(5), 1408–1416.

Article  CAS  PubMed  Google Scholar